Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the phenylmorpholine class, specifically a benzamide derivative. It features a morpholine ring, fluorine substitution, and an indole moiety linked to a pyridine group. The compound has been described as having potential biological activities but is primarily referenced in chemical and preclinical research databases. Its precise mechanism of action and therapeutic indication are not established in the literature or clinical trial registries as of now[1][3][6]. No approved medical use or advanced clinical development status is reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-fluoro-5-morpholin-4-yl-N-[1-(2-pyridin-4-ylethyl)-1H-indol-6-yl]benzamide.